Home » Topics » Regulatory

Regulatory
RSS

European Commission adopts EMEA recommendations for Arcoxia 90 mg

Oct. 2, 2008

Aclasta approved in Europe for osteoporosis in men with high risk of fractures

Oct. 1, 2008

CHMP issues positive opinion for olanzapine long-acting injection in schizophrenia

Sep. 29, 2008

Xarelto approved in Canada for prevention of venous thromboembolic events

Sep. 17, 2008

FDA approves Gamunex for inflammatory demyelinating polyneuropathy

Sep. 17, 2008

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

SF-1019 approved in Malaysia

Aug. 13, 2008

FDA approves Cleviprex for hypertension when oral therapy is not feasible

Aug. 5, 2008

European Commission approves Schering-Plough's Bridion

July 30, 2008

Health Canada grants approval to Santhera's Catena in Friedreich's ataxia

July 25, 2008

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...